Nuvation Bio Inc. (NUVB)

Nuvation Bio Revenue

Nuvation Bio had revenue of $83.23M in the quarter ending March 31, 2026, with 2,598.70% growth. This brings the company's revenue in the last twelve months to $143.05M, up 1,205.52% year-over-year. In the year 2025, Nuvation Bio had annual revenue of $62.90M with 698.96% growth.

• Revenue (ttm): $143.05M
• Revenue Growth: +1,205.52%
• P/S Ratio: 15.48
• Revenue / Employee: $465,948
• Employees: 307
• Market Cap: 2.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	62.90M	55.03M	698.96%
Dec 31, 2024	7.87M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error